Thursday 20 October 2011
Hosted by: Fasken Martineau
Organised by: Asia-Pacific Technology Network
Speaker
There is a continuing massive investment in the Gulf region's healthcare sector, with $60 billion being invested in Saudi Arabia alone. This provides a market for the pharmaceutical companies, but also is a major market for those providing hospitals, medical equipment and healthcare. This seminar will look at recent developments in the region, and will ask how British and wider European involvement can be encouraged.
Dr Shahid Raza has over 20 year’s experience of the region having worked in diverse roles for major multinationals GSK and ROCHE. His experience includes R&D, medical affairs, marketing, sales and regulatory. He has also gained an in-depth understanding and knowledge of drug development. His experience covers strategic and clinical development across therapeutic areas including Diabetes, Oncology, Asthma, Hepatitis, Depression and Gastroenterology. Currently runs a consultancy after a career in which he ended as Director Medical Affairs, Africa Middle East for Glaxo Smith Kline International. Earlier, he worked seven years for Glaxo Wellcome in Saudi Arabia, having started his career in Pakistan (with Roche and Glaxo). He is also involved with TASS - Targeting Asthma in Sub-Saharan Africa.
Location: Fasken Martineau, 17 Hanover Square London W1S 1HU
Nearest tube station: Oxford Circus
Timing: Registration from 17:00: seminar from 17:30 - 19.15 (followed by refreshments)
Pricing:
To Register your interest- please send your details (name, institutional affiliation, email address, phone number - and the category you come under) to biz22@aptn.org